Clinical Trial Update: Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intradermal etanercept for remission induction in discoid lupus erythematosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Discoid Lupus Erythematosus
• Lupus Erythematosus Chronic Cutaneous
• Lupus Erythematosus Cutaneous

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: University of Leeds | Conditions: Lupus Erythematosus, Discoid, Lupus Erythematosus, Cutaneous | Phase 2 | Status: COMPLETED